4.7 Article

Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Effect of Dietary Selenium and Cancer Cell Xenograft on Peripheral T and B Lymphocytes in Adult Nude Mice

Wen-Hsing Cheng et al.

BIOLOGICAL TRACE ELEMENT RESEARCH (2012)

Article Oncology

Role of IL-17A in the development of colitis-associated cancer

Yil Sik Hyun et al.

CARCINOGENESIS (2012)

Review Immunology

From Murine to Human Nude/SCID: The Thymus, T-Cell Development and the Missing Link

Rosa Romano et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Article Medicine, Research & Experimental

Extrathymic development of murine T cells after bone marrow transplantation

Amanda M. Holland et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Oncology

Targeting the Inhibitor of Apoptosis Proteins as a Novel Therapeutic Strategy in Medulloblastoma

Joanna Keating et al.

MOLECULAR CANCER THERAPEUTICS (2012)

Article Biochemistry & Molecular Biology

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

J. H. Oh et al.

ONCOGENE (2011)

Article Pathology

Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma

Helder Antonio Rebelo Pontes et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2010)

Article Oncology

Guidelines for the welfare and use of animals in cancer research

P. Workman et al.

BRITISH JOURNAL OF CANCER (2010)

Article Gastroenterology & Hepatology

Inhibitor of κB Kinase Beta Regulates Gastric Carcinogenesis via Interleukin-1α Expression

Kei Sakamoto et al.

GASTROENTEROLOGY (2010)

Article Biochemical Research Methods

Interleukin-32 Gamma Specific Monoclonal Antibody and Developing IL-32 Specific ELISA

Siyoung Lee et al.

HYBRIDOMA (2010)

Article Otorhinolaryngology

Keratocystic odontogenic tumor associated with nevoid basal cell carcinoma syndrome: Similar behavior to sporadic type?

Adriana Figueroa et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2010)

Editorial Material Oncology

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

Jacqueline Bromberg et al.

CANCER CELL (2009)

Review Biotechnology & Applied Microbiology

OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls

Veronique Baud et al.

NATURE REVIEWS DRUG DISCOVERY (2009)

Article Multidisciplinary Sciences

aPKCλ/ι promotes growth of prostate cancer cells in an autocrine manner through transcriptional activation of interleukin-6

Hitoshi Ishiguro et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Oncology

STATs in cancer inflammation and immunity: a leading role for STAT3

Hua Yu et al.

NATURE REVIEWS CANCER (2009)

Article Biochemistry & Molecular Biology

The STAT3 NH2-terminal Domain Stabilizes Enhanceosome Assembly by Interacting with the p300 Bromodomain

Tieying Hou et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Immunology

Re-educating tumor-associated macrophages by targeting NF-κB

Thorsten Hagemann et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2008)

Review Multidisciplinary Sciences

Cancer-related inflammation

Alberto Mantovani et al.

NATURE (2008)

Review Medicine, Research & Experimental

A cytokine-mediated link between innate immunity, inflammation, and cancer

Wan-Wan Lin et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Immunology

General nature of the STAT3-activated anti-inflammatory response

Karim C. El Kasmi et al.

JOURNAL OF IMMUNOLOGY (2006)

Review Oncology

Distinct role of macrophages in different tumor microenvironments

CE Lewis et al.

CANCER RESEARCH (2006)

Article Oncology

Potent antitumor activity of interleukin-27

M Hisada et al.

CANCER RESEARCH (2004)

Review Oncology

NF-κB in cancer:: From innocent bystander to major culprit

M Karin et al.

NATURE REVIEWS CANCER (2002)

Review Biochemistry & Molecular Biology

The hallmarks of cancer

D Hanahan et al.

Article Immunology

Human NK-cell receptors

L Moretta et al.

IMMUNOLOGY TODAY (2000)